GenSci, RTW Investments, and Yarrow Bioscience Enter Strategic Global Partnership to Advance First-in-Class Anti-TSHR Antibody for Graves’ Disease and Thyroid Eye Disease SHANGHAI & NEW YORK Shanghai Scizeng Medical Technology Co LTD, a subsidiary of Changchun GeneScience Pharmaceutical (“GenSci”), together…
Washington State Expands Access to Life-Saving Medications for Opioid Use Disorder with New Provider Resource Library In a major step forward in Washington State’s ongoing response to the opioid crisis, the Washington State Health Care Authority (HCA) and the Department…
PDUFA Date Extended for Aldeyra’s Reproxalap Dry Eye NDA Aldeyra Therapeutics a biotechnology company focused on the discovery and development of innovative therapies for immune-mediated and inflammatory diseases, has announced that the U.S. Food and Drug Administration (FDA) has extended…
Natera and MEDSIR Partner on MiRaDoR Trial to Advance Genome-Guided Treatment Strategies in HR+/HER2- Breast Cancer Natera a global leader in cell-free DNA (cfDNA) testing and precision medicine, and MEDSIR (Medica Scientia Innovation Research), an international clinical research organization specializing…
Innoviva Specialty Therapeutics, a subsidiary of Innoviva, today announced that the U.S. Food and Drug Administration (FDA) has approved NUZOLVENCE (zoliflodacin) for oral suspension, a first-in-class, single-dose oral antibiotic for the treatment of uncomplicated urogenital gonorrhea in adults and adolescents…
Research And Markets has announced the addition of the “Diabetic Neuropathy Market Report: Trends, Forecast and Competitive Analysis to 2031” to its expanding portfolio of healthcare and life sciences market intelligence reports. According to the report, the global diabetic neuropathy…
Elevance Health Reflects On The Evolving Role Of Health Plans By simplifying the healthcare experience, strengthening care coordination, and applying data-driven insights, Elevance Health and its affiliated health plans are redefining how members engage with healthcare helping individuals and families…
SBC Medical Group Holdings Completes Strategic Tender Offer for Waqoo, Strengthening R&D and Regenerative Medicine Capabilities SBC Medical Group Holdings Incorporated (“SBC Medical” or the “Company”), a global provider of integrated consulting, operational management, and strategic support services for medical…
Darling Ingredients and Tessenderlo Group Advance Strategic Partnership With Definitive Agreement to Form New Global Collagen Company Darling Ingredients announced that it has entered into a definitive agreement with Tessenderlo Group to formally combine the collagen and gelatin divisions of…
Cerus Corporation Announces Group Purchasing Agreement with Blood Centers of America, Expanding Access to Pathogen Reduction Technologies CONCORD Calif Cerus Corporation announced that it has finalized a new group purchasing agreement with Blood Centers of America the largest blood supply…